News

Covid-19: 1,445 cases linked to Tablighi Jamaat event; total cases rise to 4,067

PTI New Delhi | Updated on April 08, 2020 Published on April 06, 2020

A technician from a lab in Delhi demonstrates before the mediapersons, sample collection process for COVID-19 tests, in New Delhi, Monday, April 6,2020.   -  PTI

Death toll jumps to 109

Out of the total 4,067 cases of coronavirus in the country, at least 1,445 have been found to be linked to the Tablighi Jamaat congregation in Delhi, the Union health ministry on Monday.

This map tracks the total number of confirmed COVID-19 cases across India's States, along with the number of Indian nationals and the number of foreign nationals affected. It also tracks the number of recoveries and deaths in each State, which are included in the total number of confirmed cases.

The map is updated based on a combination of numbers reported by the central Health Ministry, and updates from the States. 

The ministry’s updated data came a day after it said the rate of doubling of Covid-19 cases in India accelerated to 4.1 days from the estimated 7.4 days due to the Jamaat event in Nizamuddin West last month.

Joint Secretary in the ministry Lav Agarwal said there had been 693 new Covid-19 cases and 30 deaths since Sunday. The total death toll now stands at 109.

However, a PTI tally based on figures reported by States directly showed at least 126 deaths across the country, while the confirmed cases reached 4,111. Of them, 315 have been cured and discharged.

On AIIMS Director Randeep Guleria reportedly saying that there has been “localised community transmission” in some parts of the country, Agarwal commented, “What the director has said is not in variance with what we have been explaining to you. He said localised community transmission, which implies a larger number of cases have been found in a particular area.”

Males account for 73 per cent deaths due to Covid-19, while females 27 per cent, Agarwal said, adding that 63 per cent deaths have been reported among people above 60 years.

According to an ICMR official, there is limited evidence on the efficacy of hydroxychloroquine to deal with Covid-19 cases and therefore, there is not enough proof to advise it for the general public.

Published on April 06, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.